Exenatide versus Insulin Lispro Added to Basal Insulin in a Subgroup of Korean Patients with Type 2 Diabetes Mellitus

BACKGROUND: The prevalence of type 2 diabetes mellitus (T2DM) and obesity is increasing in Korea. Clinical studies in patients with T2DM have shown that combining the glucagon-like peptide-1 receptor agonist exenatide twice daily with basal insulin is an effective glucose-lowering strategy. However,...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoon, Kun-Ho, Hardy, Elise, Han, Jenny
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Diabetes Association 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328698/
https://www.ncbi.nlm.nih.gov/pubmed/28029018
http://dx.doi.org/10.4093/dmj.2017.41.1.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328698/
https://www.ncbi.nlm.nih.gov/pubmed/28029018
http://dx.doi.org/10.4093/dmj.2017.41.1.69

Ejemplares similares